Edition:
United Kingdom

Insider Trading: Dicerna Pharmaceuticals Inc (DRNA.OQ)

DRNA.OQ on NASDAQ Stock Exchange Global Select Market

8.83USD
19 Jan 2018
Change (% chg)

$-0.14 (-1.56%)
Prev Close
$8.97
Open
$8.92
Day's High
$8.97
Day's Low
$8.61
Volume
41,530
Avg. Vol
70,717
52-wk High
$10.24
52-wk Low
$2.43

All Insider Trades
Trading Date Name Title Type Shares Traded Price
18 Dec 2017

Bain Capital Life Science Investors, L.L.C.

Director and Beneficial Owner Buy 8,454,388 $0.00
18 Dec 2017

DOMAIN PARTNERS VIII L P

Beneficial Owner of More than 10% Class Buy 1,678,432 $3.19
18 Dec 2017

DP VIII ASSOCIATES L P

Beneficial Owner of More than 10% Class Buy 282 $0.00
18 Dec 2017

Bain Capital Life Science Investors, L.L.C.

Director and Beneficial Owner Buy 285,000 $7.00
18 Dec 2017

RA Capital Management, L.L.C.

Beneficial Owner of More than 10% Class Buy 2,645,442 $0.00
18 Dec 2017

DP VIII ASSOCIATES L P

Beneficial Owner of More than 10% Class Buy 12,444 $3.19
18 Dec 2017

Kolchinsky (Peter Ph.D.)

Director Buy 2,645,442 $0.00
18 Dec 2017

Bain Capital Life Science Investors, L.L.C.

Director and Beneficial Owner Buy 190,849 $0.00
18 Dec 2017

DOMAIN PARTNERS VIII L P

Beneficial Owner of More than 10% Class Buy 37,890 $0.00
16 Nov 2016

Langer (Dennis H)

Director Sell 23,766 $3.52
15 Nov 2016

Fambrough (Douglas M III)

Chief Executive Officer Buy 16,500 $3.63
14 Nov 2016

Fambrough (Douglas M III)

Chief Executive Officer Buy 16,600 $3.78
12 May 2016

Weissman (James B)

Officer Buy 4,170 $3.29
12 May 2016

Weissman (James B)

Officer Buy 300 $3.24
12 May 2016

Weissman (James B)

Officer Buy 530 $3.29
3 Feb 2016

Langer (Dennis H)

Director Buy 34,722 $3.42

Institutional Holders

% Shares Owned: 62.20%
# of Holders: 51
Total Shares Held: 32,121,645
3 Mo. Net Change: 17,257,764
# New Positions: 3
# Closed Positions: 0
# Increased Positions: 6
# Reduced Positions: 1
# Net Buyers: 5

Officers & Directors

Name Age Since Current Position

David Madden

53 2009 Independent Chairman of the Board

Douglas Fambrough

46 2013 President, Chief Executive Officer, Director

John Green

62 2016 Chief Financial Officer, Principal Financial Officer

Bob Brown

50 2012 Senior Vice President, Chief Scientific Officer

Theodore Ashburn

47 2014 Senior Vice President - Product Strategy & Operations

Pankaj Bhargava

46 2014 Chief Medical Officer

Ralf Rosskamp

63 2017 Chief Medical Officer

James Weissman

53 2012 Chief Business Officer

Martin Freed

54 2016 Independent Director

Brian Halak

45 2010 Independent Director

Stephen Hoffman

62 2007 Independent Director

Peter Kolchinsky

40 2013 Independent Director

Dennis Langer

66 2007 Independent Director

Bruce Peacock

65 2014 Independent Director